McGuire Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$132K Sell
1,025
-1,960
-66% -$229K 0.07% 117
2026
Q1
$359K Buy
2,985
+529
+22% +$61.1K 0.23% 60
2025
Q4
$259K Buy
+2,456
New +$231K 0.16% 74

Other funds holding MRK

McGuire Capital Advisors's MRK Position: Q2 2026 in Review

McGuire Capital Advisors reduced its Merck (MRK) stake by 66% in Q2 2026, selling an estimated $229K and leaving 1,025 shares worth $132K. The position accounts for 0.07% of the portfolio, ranked #117.

McGuire Capital Advisors first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $359K in Q1 2026. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • McGuire Capital Advisors held 1,025 shares of Merck worth $132K as of Q2 2026.
  • McGuire Capital Advisors sold 1,960 Merck shares in Q2 2026, an estimated $229K.
  • Merck made up 0.07% of McGuire Capital Advisors's portfolio in Q2 2026, its #117 holding.
  • McGuire Capital Advisors first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • McGuire Capital Advisors's Merck position peaked at $359K in Q1 2026.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on McGuire Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.